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ABSTRACT 
 
Background: Improved functional capacity (FC) and inflammatory marker reduction is 
a good prognostic factor in post-revascularization cardiac patients. However, there is 
still limited study investigated association of functional capacity and inflammatory 
marker after cardiac rehabilitation program. We studied the effects of cardiac 
rehabilitation (CR) program in the improvement of FC and high-sensitive-C Reactive 
Protein (hs-CRP) reduction and association between those variables. 
Methods: This was quasi experimental study in post-revascularization CAD patients 
who attended phase II CR program at CR gymnasium, Dr. Hasan Sadikin General 
Hospital, Bandung, from October 2014 to May 2015. The CR program included 
additional education sessions and consistently strict program intensity on 50-80% heart 
rate reserve based on formula and Borg scale 11 to 15. Functional capacity and hs-
CRP were measured before and after the program. Functional capacity was assessed 
by maximal treadmill test through indirect VO2 max measurement. 
Results: A total of 37 patients aged 56.05±7.3 years old were analyzed in this study. 
They consisted mainly of men (81.1%) which 78.4% of them underwent percutaneous 
coronary intervention (PCI). Our study revealed significant FC improvement after 
completion of this newly-modified CR program from an average of 6.76 to 8.68 METs 
(28.4%) ( p<0.001). Hs-CRP reduction was also occurred from mean of 0.49 mg/L to 
0.20 mg/L (59.2%) of log hs-CRP level (p= 0.005). Linear regression analysis showed 
the improvement of fitness was associated with baseline FC (p<0.001) and reduction of 
hs-CRP was associated with baseline hs-CRP (p<0.001), and not influenced by age, 
gender, ejection fraction and type of procedure. There is moderate correlation (rs= 
0.636, p<0.001) between functional capacity improvement and hs-CRP reduction. Each 
1 METs improvement can reduce 9.317 mg/L of transformed hs-CRP level (p=0.006, 
95%CI 2.942,15.693). 
Conclusions: CR program significantly increased functional capacity and reduce hs-
CRP level in post-revascularization CAD patient, and more prominent in a patient with 
low baseline functional capacity and high hs-CRP level. Functional capacity 
improvement and hs-CRP reduction were moderately correlated. 
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INTISARI 
 
Latar belakang: Peningkatan kapasitas fungsional dan penurunan penanda inflamasi 
merupakan suatu faktor prognostik yang baik pada pasien pasca revaskularisasi 
jantung. Namun studi mengenai hubungan antara kapasitas fungsional dan penanda 
inflamasi masih terbatas. Penelitian ini bertujuan mempelajari pengaruh program 
rehabilitasi jantung terhadap perbaikan kapasitas funsional dan penurunan high-
sensitive-C Reactive Protein (hs-CRP) serta asosiasi di antara kedua variable tersebut. 
Metode: Studi eksperimental-kuasi dilakukan pada pasien penderita penyakit arteri 
koroner pasca revaskularisasi yang menjalani program rehabilitasi jantung fase II di 
pusat kebugaran rehabilitasi jantung, Rumah Sakit Umum Pusat Dr. Hasan Sadikin, 
Bandung dari Bulan Oktober 2014 sampai Mei 2015. Program baru ini meliputi sesi 
edukasi tambahan dan secara konsisten menggunakan intensitas latihan 50-80% dari 
cadangan laju denyut jantung berdasarkan formula dan skala Borg 11 sampai 15. 
Kapasitas fungsional dan kadar hs-CRP dalam darah diukur sebelum dan setelah 
menjalani program. Kapasitas fungsional dinilai dengan menggunakan tes ban berjalan 
maksimal, melalui pengukuran VO2 max secara tidak langsung.  
Hasil: Sebanyak 37 pasien dianalisis dalam studi ini. Sebagian besar subjek (81.1%) 
berjenis kelamin laki-laki, dengan usia rata-rata 56.05 ± 7.3 tahun dimana 78.4% 
subjek merupakan pasien pasca intervensi koroner perkutan. Penelitian kami 
menunjukkan bahwa kapasitas fungsional meningkat secara bermakna dari rata-rata 
6.76 METs menjadi 8.68 METs (peningkatan sebanyak 28.4%) dengan p<0.001 
setelah menjalani program baru rehabilitasi jantung termodifikasi. Penurunan hs-CRP 
juga terjadi dari  rata-rata nilai log hs-CRP 0.49 mg/L ke 0.20 mg/L (59.2%) (p= 0.005). 
Hasil analisis regresi linear menunjukkan bahwa perbaikan dari kebugaran berkaitan 
dengan kapasitas fungsional awal (p<0.001), dan penurunan hs-CRP berkaitan 
dengan kadar log hs-CRP awal (p<0.001), dan tidak dipengaruhi oleh usia, jenis 
kelamin, fraksi ejeksi dan tipe prosedur. Terdapat korelasi derajat sedang (rs= 0.636, 
p<0.001) antara perbaikan kapasitas fungsional dan penurunan hs-CRP. Setiap 
perbaikan 1 METs dapat menurunkan 9.317 mg/L kadar hs-CRP yang telah 
ditransformasi (p=0.006, 95%CI 2.942,15.693). 
Kesimpulan: Program baru rehabilitasi jantung meningkatkan kapasitas fungsional 
dan menurunkan kadar hs-CRP secara bermakna pada pasien penyakit arteri koroner 
pasca revaskularisasi, dimana hal tersebut lebih terlihat jelas pada pasien dengan 
kapasitas fungsional awal yang rendah dan kadar hs-CRP awal yang tinggi. Terdapat 
korelasi yang bersifat moderat antara perbaikan kapasitas fungsional dan penurunan 
hs-CRP. 
 
INTRODUCTION 
 
Cardiovascular disease has 
become a global health problem in 
worldwide countries, including 
Indonesia.1–3 Advances in technology 
and medicine has brought better 
survival rate in coronary artery disease 
patients in the last decades.4 Despite 
the fact that reduction of coronary 
artery disease (CAD) morbidity and 
mortality by improvement in coronary 
artery bypass graft (CABG) and 
percutaneous coronary intervention 
(PCI) technique, the rate of myocardial 
reinfarction and CAD-related 
rehospitalization are still high. In the 
United States, overall 30-day 
readmission rate was 14.5% of which 
8.3% caused by cardiac disease, and 
post-acute myocardial infarction 90-day 
readmission rate was 24%. It was 
estimated to cost country about $1.1 
billion for 30-day readmissions.5 To 
overcome this situation, cardiac 
rehabilitation (CR) as secondary 
prevention program needs to be 
optimized. 
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Improved functional capacity 
(FC) is a better prognostic factor in 
post-revascularization cardiac patients. 
It is proven to improve quality of life, 
decrease cardiovascular event and 
reduce mortality.6 Improvement of FC 
could be achieved by aerobic exercise 
as its cardioprotection and decrease 
post-stenting late lumen loss effects, 
contribute to decreasing in restenosis 
rate.7 Aerobic exercise increased 33% 
of FC and 16% of maximal oxygen 
intake (VO2max).
6 Myers et al. showed 
every improvement of 1 metabolic 
equivalents (METs) in functional 
capacity reduced 12% of mortality risk 
in cardiovascular patients.8 
 Inflammation parameter is 
highly correlated with atherosclerosis 
process and could accurately predict 
future cardiovascular event in healthy 
population.9–11 Inflammation parameter 
is also used as successful of treatment 
and secondary prevention indicator.12 
Several studies in post-cardiac 
rehabilitation among CAD patients in 
various population showed significant 
reduction of 0.7–2.1 mg/L in 
inflammatory mediators level.13–15 
 Inflammatory marker such as 
high-sensitive-C Reactive Protein (hs-
CRP) level is reported inversely 
associated with FC in normal 
population as well as patients with 
CAD.16–18 Prognostic impact of FC 
improvement in mortality was thought 
mediated by its inflammation reduction 
effect.18 However,there is still limited 
study investigated association of FC 
and inflammatory marker after CR 
program in post revascularization CAD 
patient. The aim of this study was to 
investigate the effects CRprogram in 
improvement of FC and hs CRP level 
and their association after CR program. 
 
METHODS 
 
Ethical Statement  
All subjects were informed 
about the possible risks of the 
investigation before giving written 
informed consent to participate. All 
procedures were through evaluation 
and approval by Dr. Hasan Sadikin 
General Hospital research ethic 
committee with ethical clearance 
number LB.04.01/A05/EC/442/X/2014. 
 
Subject  Recruitment 
 Subjects were recruited 
consecutively from cardiac prevention 
and rehabilitation/cardio-respiration 
clinic Dr.Hasan Sadikin General 
Hospital, Bandung, Indonesia. All post-
revascularization CAD patients were 
screened with initial assessment 
protocol consisted of history taking, 
physical examination, baseline data 
(echocardiography, angiography, and 
laboratory) collecting, assessment of 
indication and contraindication for 
rehabilitation program, as well as risk 
stratification based on American 
Association of Cardiovascular and 
Pulmonary Rehabilitation (AACVPR) 
criteria19 (Figure 1).  
Patients enrolled in this study 
included patients who (1) underwent 
cardiac revascularization (CABG or 
PCI); (2) attended phase II CR program 
at CR gymnastium, Dr. Hasan Sadikin 
General Hospital, Bandung, from 
October 2014 until May 2015; (3) 
absence of contraindication for 
rehabilitation exercise; (4) volunteered 
to attend for at least two sessions a 
week until a total of twelve sessions; (5) 
absence of cardiac revascularization 
schedulewithin the next six weeks; (6) 
absence of neuromusculoskeletal/ 
physiciatry comorbidity which able to 
disrupt communication, exercise 
capability, and maximal functional 
capacity assesment; (7) absence of 
autoimmune or inflammatory disease 
which able todisrupt inflammation 
parameter result; and (8) volunteered to 
be participant and signed an informed 
consent.  
 
Functional Capacity Examination 
 All subjects underwent maximal 
exercise stress test based on the 
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recommendation from European 
Association for Cardiovascular 
Prevention and Rehabilitation 
(EACPR), American Association of 
Cardiovascular and Pulmonary 
Rehabilitation (AACVPR), Canadian 
Association of Cardiac Rehabilitation 
(CACR)19, European Society of 
Cardiology20 and American Heart 
Association21 cardiac rehabilitation 
program. Exercise stress test using GE 
T-2100 treadmill without respiratory gas 
analysis with Bruce or modified Bruce 
protocol, adjusted to patient ability 
estimation based on 6-minutes walk 
test result at phase I CR program. The 
speed and inclination of treadmill test 
were increased every 3 minutes until 
subject felt exhausted (Borg scale 
above 17). Functional capacity was 
determined based on indirect VO2 max 
estimation by converting treadmill test 
duration into METs. 
 
Cardiac rehabilitation program 
 Duration of the program was 
four to eight weeks (twice weekly), 
consisted of 6 to 12 education sessions 
and supervised aerobic exercises 
(using ergocycle and treadmill). Aerobic 
exercise was held for 30 minutes of 
moderate intensity [50-80% heart rate 
reserve (from entrance maximal 
treadmill test) and Borg scale 11-15] 
with continuous training method. The 
subject complaint, blood pressure, 
pulse, and oxygen saturation were 
recorded. The home exercise program 
was also prescribed. Furthermore, each 
patient was given personal health 
education included cardiac anatomy, 
exercise, sexual activity and healthy 
diet with educational video program. 
hs-CR 
Venous blood samples were 
collected and examined in clinical 
pathology department Dr. Hasan 
Sadikin Hospital. The quantitative 
measurement of CRP was performed 
using a particle enhanced immune-
turbidimetric assay integrated with 
Cobas C 311 automated chemistry 
analyzer (Indianapolis, USA). Human 
CRP agglutinates with latex particles 
coated with monoclonal anti-CRP 
antibodies. The precipitate was 
determined turbidimetrically, samples 
dispensed and all processes done 
automatically and concentration 
obtained for each sample.Lower 
detection limit of hs-CRP was 0.15 
mg/L (1.43 nmol/L, 0.015 mg/dL)with 
functional sensitivity 0.3 mg/L (2.96 
nmol/L, 0.03 mg/dL).22 
Drop out 
 All subjects who (1) absence 
from exercises for consecutive three 
weeks; (2) attended exercise less than 
six times in eight weeks; (3) had 
serious exercise complication; and (4) 
had incomplete data; were dropped out 
from the study. 
Statistical Analysis  
 This was a quasi experimental 
study. The differences between FC and 
hs-CRP before and after the program 
were analyzed with paired t-test using 
SPSS 21.0. Related factors were 
examined with Spearman’s /Pearson’s 
correlation, Mann- Whitney U/ 
independent t-test analysis and Fisher’s 
exact test, based on type and 
distribution of data. Multivariate 
analysis was performed to evaluate 
significance of baseline FC and 
baseline hs-CRP as predictors of FC 
improvement and hs-CRP reduction 
after CR program. All P-values < 0.05 
were considered statistically significant. 
 
RESULT 
 
Forty-four patients were enrolled in this 
study with seven of them were 
excluded (four drop-outs, one loss to 
follow-up and two incomplete 
procedures). A total of 37 subjects were 
analyzed for functional capacity 
improvement. Mean age of subject was 
56.05±7.3 years old, range 37-73 years 
old. Thirty subjects (81.1%) were male, 
seven subjects (18.9%) were female. 
Majority of our subjects had a minimum 
of senior high school level of education 
(70.3%). 
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Figure 1.  Flow of participants through the trial 
CAD= coronary artery disease, TMT= treadmill test, hs-CRP= high sensitive C-Reactive Protein 
 
 
 
 
Post-revascularization CAD patients 
(History taking & physical examination) 
 
Data collection 
(Echocardiography, angiography, laboratory 
data) 
 
 
 
Data report and analysis  
Informed consent 
Inclusion criteria 
 
- Baseline functional capacity assessment (maximal test - 
TMT) 
- Baseline hs-CRP assesment 
 
 
 
 
Phase II cardiac rehabilitation program 
- Functional capacity assessment (maximal test - 
TMT) 
- hs-CRP assesment 
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 Absence of exercise 
for consecutive 3 
weeks 
 < 6 sessions of 
exercise 
 
 2 
 
Incomplete data   
exclude 
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BMI= body mass index; CAD= coronary artery disease; VD= vessel disease; PCI=  percutaneous coronary 
intervention; CABG= coronary artery bypass graft 
 
Mean of body mass index (BMI) 
was 25.32 kg/m2 and classified as 
overweight.23 Subjects with diabetes 
mellitus (DM), hypertension, 
dyslipidemia, family history and 
smoking history were 13.5 %, 59.5 %, 
70.3 %,29.7 %, and 75.7% 
consecutively. Our coronary 
angiography profile revealed 37.8% 
patients had three vessel CAD. 
Furthermore, most of subjects (89.2%) 
had preserved ejection fraction (EF 
>40%) and 78.4% of subjects 
underwent for PCI. Meanwhile, 21.6% 
of subjects underwent CABG for a re- 
vascularization procedure (Table 1).  
Functional Capacity Improvement  
 Our study found significant 
improvement in FC from 6.76±1.94 to 
8.68±1.60 METs (p<0.001), with a 
difference of 1.92 METs after 
completed this CR program. The 
median of METs differences was 1.68 
METs. Then, we analyzed FC 
improvement related factors. Our 
bivariate analysis showed age, gender, 
diabetes mellitus, hypertension, 
dyslipidemia, smoking history, and type 
of procedure were not associated with 
FC level improvement after completed 
CR program. However, the EF had a 
low negative correlation(rs=-0.358, 
p=0.030), baseline FC had a moderate 
negative correlation (rs= -0.552, 
p<0.001),  and baseline hs-CRP  level 
had a lowpositive correlation (rs= 0.461, 
p=0.004) with FC improvement (Table 
2).
 
 
Table 1. Baseline characteristics of participants 
 
Variables 
 
n % 
Age (years, mean±SD ) 
 
56.05±7.3 
 
Gender 
 
  
    Male 
 
30 81.1 
    Female 
 
7 18.9 
Level of education 
        < Senior high school 
 
11 29.7 
     ≥ Senior high school 
 
26 70.3 
Risk factor 
 
  
     BMI (kg. m-2, mean±SD) 
 
25.32±2.6 
 
     Diabetes mellitus 
 
5 13.5 
     Hypertension 
 
22 59.5 
     Dyslipidemia 
 
26 70.3 
     Family history 
 
11 29.7 
     Smoking  28 75.7 
Angiography result 
 
  
     CAD 1 VD 
 
11 29.7 
     CAD 2 VD 
 
12 32.4 
     CAD 3 VD 
 
14 37.8 
Ejection Fraction 
        >40% 
 
33 89.2 
     ≤40% 
 
4 10.8 
Procedure 
 
  
     PCI 
 
29 78.4 
       Acute coronary syndrome  20 54.1 
       Elective PCI  9 24.3 
     CABG   8 21.6 
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Figure 2. Improvement in functional capacity and in log hs-CRPlevel after CR program 
 
Table 2.  Correlation of baseline characteristics, echocardiographic and laboratory 
parameters with functional capacity improvement and hs-CRP reduction 
 
  
Functional capacity 
improvement 
hs-CRP reduction 
Age
$+
 r= -0.051, p=0.763  rs= -0.096, p=0.560 
BMI
$
 r= -0.044, p=0.797 rs= -0.036, p=0.831 
Ejection fraction
&
 rs= -0,358, p=0.030 rs= -0.272,  p= 0.104 
Baseline FC level
$
 r= -0.552, p<0.001  rs=-0.383, p=0.019 
Baseline hs-CRP level
&
 rs=0.461, p=0.004 rs=0.724, p=<0.001 
Gender
%
 p=0.329 p=0.727 
Diabetes mellitus
%
 p=0.531 p=0.213 
Hypertension
%
 p=0.950 p=0.567 
Dyslipidemia
%
 p=0.671 p=0.135 
Smoking 
%
 p=0.205 p=0.357 
Type of procedure
%
 p=0.058 p=0.001 
 
$
Pearson’s correlation; 
&
 Spearman’s correlation; 
%
Mann-Whitney U test 
+Logarithmic transformation was used to normalize the data 
There was an association between 
baseline FC and FC improvement after 
adjusting for confounders (Table 3). 
Patient with 1 METs lower of baseline 
FC will obtain functional capacity 
improvement of 0.401 higher after CR. 
Baseline hs-CRP has a tendency to 
predict FC improvement. However, in  
model 1 adjustment, this relation was 
not significant (Table 3). We suggest 
age or gender is a strong confounder 
interrupted baseline hs-CRP effect 
towards FC improvement. Linear 
regression analysis also showed 
ejection fraction was not a significant 
predictor of FC improvement. 
 
Hs-CRP Reduction 
 Fourteen patients (37.8%) had 
high baseline of  hs-CRP level (>3 
mg/L). Hs-CRP level was also reduced 
significantly after completion of CR 
program (p = 0.005).  A total of 29 
subjects (78.4%) had a hs-CRP 
reduction (mean log baseline of hs-
CRP was 0.49 mg/L reduced to 0.20 
mg/L), with difference 0.29 mg/L 
(59.2%) of log hs-CRP level (Figure 2). 
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There was a significant 
difference in hs-CRP reduction between 
two types of procedure. Baseline FC 
level and baseline hs-CRP were lowly 
and highly correlated with hs-CRP 
reduction, respectively. After adjusting 
for baseline FC and other confounders, 
there was association between baseline 
hs-CRP level and hs-CRP reduction 
(Table 4). Patient with 1 mg/L higher of 
baseline hs-CRP on average would 
obtain hs-CRP reduction of 0.877 mg/L 
higher after CR. However, baseline FC 
and type of procedure were not 
significant predictors for hs-CRP 
reduction.  
 Hs-CRP natural course of 
reduction was considered not interrupt 
our hs-CRP assessment in this study. 
Based on available data, we initiate CR 
program within 14 (8-35) days after 
procedure. While, hs-CRP reduction 
was started after first week and back to 
normal one month after PCI or major 
surgery.24,25  
In purpose to confirm hs-CRP 
level reduction due to exercise effect 
instead of type of cases or time related 
hs-CRP reduction, we compared hs-
CRP level between the theoretically 
higher hs-CRP cases (PCI in acute 
coronary syndrome case and CABG 
groups) and the elective PCI group. 
Based on independent T test, there 
were no significant difference in log 
baseline hs-CRP (P=0.176) and log hs-
CRP reduction (P=0.728)  between two 
groups. 
If we compare between PCI and 
CABG groups. There were significant 
difference in log baseline hs-CRP 
(P=0.007) and log hs-CRP level 
reduction (P=0.003) between two 
groups. However, there was significant 
log hs-CRP reduction between pre and 
post CR program in evey subgroup of 
cases (CABG and PCI group). It may 
propose positive confirmation of our 
hypothesis that hs-CRP level reduction 
caused by CR program independent of 
type of procedure and hs-CRP 
reduction related time. In this study, hs-
CRP reduction have a high probability 
caused by phase II CR program. 
 
Association of FC and hs-CRP 
Improvement 
 There was moderate correlation 
(rs= 0.636, p<0.001) between FC 
improvement and hs-CRP reduction. 
Furthermore, FC improvement can 
predict  hs-CRP level reduction. Each 1 
METs improvement after CR program 
can reduce 9.317 mg/L of transformed 
hs-CRP level (p=0.006,95%CI 
2.942,15.693) 
 
DISCUSSION 
 Our baseline characteristic 
showed 70.3% subjects had good level 
of education (completed senior high 
school). This characteristic was 
favorable to this study since education 
was an important element for 
rehabilitation program compliance and 
it could be reflected in small number of 
drop out patient in the study.27 We 
initiate CR program earlier; within 2 
weeks after procedure. Initiation of CR 
after 1 week leads to a 90% increase in 
participation rates compared to a 
initiation after 4 weeks.28 
 
Functional Capacity Improvement 
 This study demonstrated phase 
II CR program, consisted of hospital 
gymnasium and home exercise training 
completed with healthy lifestyle 
education, could produce significant 
improvement with an average of 1.92 
METs (28.4%) in FC and this study 
result was consistent with several 
previous studies in phase II CR 
program. Cardiac rehabilitation program 
improved FC with average of 0.43 
METs to 1.46 METs  (9.1% to 
26.8%).13,29–32 Our good result in this 
study could be explained by the low FC 
baseline of subjects as it might result in 
significant difference. A CR improve 
exercise capacity, and may be caused 
by an adaptive response involved in an 
increased capacity of endogenous anti 
oxidative systems or more efficient 
oxidative metabolites. 
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Exercise training rises the 
capillary density of the skeletal muscle, 
promotes a transformation from type II 
to type I muscle fiber,  and increases 
the amount and oxidative enzyme 
activities of mitochondria. These 
peripheral mechanisms play significant 
part in the increase in VO2 max by 
exercise training. The increase in 
exercise capacity is also assumed to be 
caused by myocardial ischemic 
threshold improvement in patients with 
CAD.33 Diabetes mellitus, hypertension, 
dyslipidemia, smoking and type of 
intervention were not associated with 
FC improvement. The CR program is 
an excellent measure to improve CAD 
patients’ quality of life and reduce 
morbidity and mortality.34 Different from 
this study, Branco et al.35 showed 
greater mean functional capacity 
improvement in age > 45 years old, non 
diabetes mellitus and post-CABG 
patients. Our patients’ age 
characteristic (97.3%) >45 years old, 
diabetes mellitus control status and 
earlier initiation of CR might lead 
differences in these findings. Early CR 
program will reduce deconditioning 
period of post-CABG patients and 
improve FC baseline in post-CABG 
patients.36 Therefore, it might result in 
no significant difference between post-
PCI and CABG patients’ post-CR FC 
improvement. Multivariate analysis 
demonstrated the baseline FC was the 
only independent predictors of FC 
improvement after completion of phase 
II CR program.  
This finding emphasized the 
phase II CR program be significantly 
improved FC independent of the 
presence of CAD risk factors and type 
of procedure. CR program appeared to 
give more benefit in a patient with 
worse condition (low FC level) 
independent to other factors. Previous 
studies were consistent with these 
findings. Shiram et al.37 showed initial 
exercise capacity as the only 
independent variable predicting 
improvement in exercise performance 
after rehabilitation program. Ades et 
al.38 study also showed the baseline 
physical function score was the only 
baseline variable that predicted change 
in physical function score after 
rehabilitation. Patients with the lowest 
baseline physical function score were 
the most likely to show an improvement 
in physical function score after 
rehabilitation.38,39 
 Ejection fraction was not an 
independent predictor of FC 
improvement in linear regression 
analysis. This result was consistent with 
a study performed by Sousa et al.40, 
which demonstrated FC improvement 
achieved after completion of CR 
program was independent of initial left 
ventricle function. Maximal oxygen 
intake depends on several parameters, 
such as ventilation, oxygen diffusion at 
lung level, peripheral perfusion and 
diffusion, and mitochondrial function 
which in several conditions have more 
important role than oxygen transport by 
circulation itself.41 Both diabetes 
mellitus and hypertension are common 
risk factors for CAD. In type 2 diabetes 
mellitus, a reduction in maximal a-v O2 
difference contributes to a decreased 
VO2 max.42 Endothelial and 
mitochondrial dysfunction also 
responsible for lower oxygen 
consumption in arterial hypertension 
patients.43 
 
hs-CRP Reduction 
 Atherosclerosis involves 
inflammation process, typically depicted 
in increase of hs-CRP level as a 
nonspecific inflammatory marker and 
predictive factor of CAD.14 This study 
showed an average reduction of 0.29 
mg/L (59.2%) in log hs-CRP level after 
CR program. This result was consistent 
with other previous studies with 
average reduction of 0.02-2.10 mg/L 
(1.3-35.6%) in hs-CRP level.13,15,44 One 
mechanism proposed to explain 
training’s CRP reduction effect is 
cytokine production reduction by 
adipose tissue, skeletal muscle,  
endothelial cells, and blood 
mononuclear cells. 
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Regular muscle movement 
during exercise may modify 
inflammation locally while systemic 
inflammation is reduced through 
muscle-derived cytokines. Muscle is 
myokine secretory organ and muscle 
contraction produces myokines 
opposing pro-inflammatory cytokines 
and reduce low-grade chronic 
inflammation.45 Exercise training may 
reduces CRP indirectly by increasing 
insulin sensitivity, improving endothelial 
function, and reducing body weight.13,46 
However, another study conducted by 
Luk et al.32, showed their cardiac 
rehabilitation training program did not 
significantly alter the subject’s hs–CRP 
level. The medium baseline of hs-CRP 
level in that study might cause this 
finding.   
Based on our study, reduction in 
hs-CRP level after CR program more 
prominent in higher baseline of  hs-
CRP level. This finding also explained 
the higher reduction of hs-CRP in this 
study than previous studies. Statin was 
not considered to affect our study result 
since all enrolled patients consumed 
statin more than one week and hs-CRP 
decreased significantly after one week 
of statin treatment (at the time we 
measured hs-CRP baseline level).47 
Our study revealed a high hs-CRP 
reduction (59.2%), which might indicate 
CR program impact on hs-CRP 
reduction besides the statins. This 
result consistent with Milani et al.13 
study which identify benefit of phase II 
CR training programs to reduce hs-
CRP with similar or greater effect than 
statin drugs. 
 We found baseline hs-CRP was 
the only significant predictor of hs-CRP 
reduction after CR program. The anti-
inflammatory effect of exercise in 
person with coronary heart disease 
may be greater because of their higher 
inflammatory levels.48 In Lakka et al49 
study with 652 sedentary healthy adult,  
hs-CRP reduced by 1.34mg/L in 
individuals who had high (3.0mg/L) 
baseline hs-CRP levels, but did not 
change among those with low (1.0 
mg/L) or moderate (1.0–3.0 mg/L) 
baseline hs-CRP levels. The difference 
in the hs-CRP change among the 
baseline hs-CRP group was still 
significant after adjustment for all 
correlates variables such as body 
weight, glucose, insulin, LDL, HDL, 
triglycerides, systolic and diastolic 
blood pressure, and maximal oxygen 
uptake. Though there is a tendency of 
significant correlation between type of 
procedure and hs-CRP reduction, type 
of case or procedure was not significant 
predictor in multivariate analysis. 
Higher baseline of hs-CRP caused 
higher hs-CRP level reduction after CR 
program in CABG group compared to 
PCI group. Since most of study of hs-
CRP in PCI or CABG patients show hs-
CRP as prognostic marker, we suggest 
hs-CRP level may not have any clinical 
association with type of 
case/procedure, and it more reflected 
patient’s prognosis.50–54 
 Association between FC and hs-
CRP level is interrelated. Patient with 
good FC has lower level of hs-CRP and 
vice versa, patient with lower FC had a 
higher hs-CRP level.18,55,56 Functional 
capacity improved prognosis 
mechanism is partly mediated by hs-
CRP lowering effect.18 Furthermore, 
high hs-CRP itself is a marker for 
impaired functional capacity.57,58 This 
study found FC improvement positively 
correlated with hs-CRP reduction after 
program. The direct mechanism of FC 
improvement to reduce hs-CRP level is 
still  unknown, and might be explained 
by exercise related effect to hs-CRP 
reduction. Our study results were 
remarkable compared with other 
previous studies, since the less 
frequency of our CR program (two 
times a week). Difficulty in access to 
CR center, social and administrative 
problems had been concerns in our 
setting. However, prescribed home 
exercise could overcome this condition. 
In our center, phase II CR program 
started earlier; in two weeks after 
procedure despite in most of previous 
CR studies, the programs were 
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initialized four weeks after 
revascularization procedure. In our 
setting, earlier CR program was needed 
to be performed since our culture of 
post-myocardial infarct or 
revascularization patients frequently 
lead to sedentary lifestyle.  
 
Limitations 
 There are several limitations in 
this study. Firstly, cardiopulmonary 
exercise test with respiratory gas 
analysis (CPX) was not used as a gold 
standard of VO2 max calculation in FC 
measurement.19,59 Equipment costs 
limited direct VO2 max measurement in 
this study. Secondly, control group was 
not involved in this study as a 
comparison of non-intervention group. 
Control group would give more benefit 
data for FC difference and hs-CRP 
reduction after intervention. Thirdly, 
supervision and documentation of 
patient’s home exercise activity were 
not conducted. Home prescribed 
exercise during CR phase II 
documentation might add more data for 
its effect in functional capacity 
improvement. Lastly, there is still a 
possibility for drugs combination, such 
as statin, angiotensin converting 
enzyme (ACE)-inhibitors, angiotensin 
receptor blockers (ARBs) and beta 
blockers (BBs) to bring attenuation 
effect on hs-CRP level. Another study 
could be performed by putting these 
limitations into account. Our finding of 
association between FC improvement 
and hs-CRP level reduction can be a 
hypothesis for the next study to show 
FC only surrogate marker in patient 
clinical improvement and clinical 
improvement can be caused by hs-CRP 
reduction.  
  In conclusion, phase II CR 
program significantly increased FC and 
reduce hs-CRP level in post-
revascularization CAD patient, and 
more prominent in patient with low 
baseline FC and high hs-CRP level. 
The FC improvement and hs-CRP 
reduction were moderately correlated. 
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